Skip to main content
MCRB logo

MCRB · Seres Therapeutics, Inc. · Short Interest

Track MCRB — free
$3.35 -0.13 (-3.74%) At close · Sep 30
Market Cap
$34.99M
Shares
9.94M
Volume · Sep 30 54.61K Avg daily vol (3M) 73.92K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

MCRB Latest Reported Short Interest

FINRA reported 301,344 MCRB shares sold short as of the September 15, 2026 settlement date, a decrease of 55,197 shares. Days to cover was 5.72 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

MCRB Short Interest Forecast

Equibles' model estimates 319,970 shares sold short for the September 30, 2026 settlement, +6.2% versus the latest reported position, with a likely range of 267,771 to 388,777 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 High confidence 69% chance it rises
319,970 +6.2% vs reported
Likely range 267,771 to 388,777 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
49/100
Short interest 3.0% of shares — P58 Days to cover 5.7 — P70 Price vs VWAP -37.6% — P5 Short-volume trend +3.7% — P62 Short interest change -15.5% — P16 Worst FTD 0.01% of shares — P57

Positioning score 48.5 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-01 12:31 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 Scheduled
FINRA publishes Oct 9
— — — —
2026-09-15 301,344 356,541 -55,197 5.72
2026-08-31 356,541 367,864 -11,323 6.11
2026-08-14 367,864 314,545 +53,319 5.42
2026-07-31 314,545 303,423 +11,122 5.92
2026-07-15 303,423 157,327 +146,096 2.00
2026-06-30 157,327 219,815 -62,488 1.32
2026-06-15 219,815 478,817 -259,002 2.15
2026-05-29 478,817 512,802 -33,985 15.52
2026-05-15 512,802 540,750 -27,948 11.08
2026-04-30 540,750 585,069 -44,319 8.79
2026-04-15 585,069 597,314 -12,245 14.88
2026-03-31 597,314 628,417 -31,103 12.06
2026-03-13 628,417 655,113 -26,696 14.30
2026-02-27 655,113 774,647 -119,534 11.24
2026-02-13 774,647 826,932 -52,285 5.04
2026-01-30 826,932 874,572 -47,640 22.13
2026-01-15 874,572 900,095 -25,523 18.72
2025-12-31 900,095 989,990 -89,895 13.22
2025-12-15 989,990 996,857 -6,867 10.85
2025-11-28 996,857 925,479 +71,378 1.65
2025-11-14 925,479 984,687 -59,208 9.58
2025-10-31 984,687 798,666 +186,021 11.50
2025-10-15 798,666 858,372 -59,706 6.83

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1609809 CUSIP 81750R201 13F (30d) 2 filings 2 filers Visit website Investor relations